Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database
These 6-month follow-up data suggest that initiating ruxolitinib cream for AD may reduce the overall need for other topical treatments, oral corticosteroids, and biologics.
Authors
- Karishma Desai (ORCID: https://orcid.org/0000-0002-7295-8280)
- Vincent J. Willey (ORCID: https://orcid.org/0000-0002-6473-6469)
- J. Z. Liu (ORCID: https://orcid.org/0009-0002-6042-5476)
- Daniel Sturm (ORCID: https://orcid.org/0009-0001-4413-8429)
- Grace Stockbower
- Chia‐Chen Teng
- Hiten Patadia
Institutions
- Wilmington University (US)
- Incyte (United States) (US)
Publication Details
- Journal
- ClinicoEconomics and Outcomes Research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/ceor.s506043
- Citations
- 6
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 12.03
Funders
- American Academy of Dermatology
- Incyte